The metabolic syndrome (MetS) is a constellation of interrelated and additive risk factors for 50 cardiovascular disease (CVD) that comprises dysglycemia, dyslipidemia, hypertension, and 51 central obesity. 1 The dyslipidemic state of MetS is characterized by raised triglycerides, low 52 HDL-cholesterol, and abnormal elevation in postprandial, apolipoprotein B48 (apoB48)-53 containing triglyceride-rich lipoproteins (TRLs), mainly composed of dietary fatty acids. 54
Subjects with MetS often have impaired glucose metabolism resulting from defects in insulin 55 secretion, insulin action, or both. 56 57 Niacin (also commonly known as nicotinic acid or vitamin B3) is a water-soluble vitamin 58 effective for lowering triglycerides and raising HDL-cholesterol. 2 Data from recent studies 59
indicated that niacin has long-term benefits in lowering postprandial secretion of apoB48 3 and 60 TRLs 4 in statin-treated patients with type 2 diabetes. Less evident are the long-term benefits 61 of niacin on postprandial glucose homeostasis in dyslipidemic patients with or without type 2 62 diabetes. 5 Of interest, the extended-release form of niacin has been shown to acutely suppress 63 postprandial hypertriglyceridemia in healthy subjects. 6 However, the role of immediate-64 release niacin dosed with a high-fat meal on postprandial insulin secretion or action and 65 hypertriglyceridemia, particularly in subjects with MetS, remains largely unknown. 
MATERIALS AND METHODS 86

Participants and design 87
Inclusion criteria for MetS consisted of at least 3 of the following components: waist 88 circumference >102 cm, fasting plasma HDL-cholesterol ≤ 1.03 mmol/l, fasting plasma 89 triglycerides ≥1.7 mmol/l, systolic blood pressure (SBP) ≥130 mmHg or diastolic blood 90 pressure (DBP) ≥85 mmHg, and fasting plasma glucose ≥5.6 mmol/l. 13 As shown in 22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 144 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w 7 relation to the difference in glucose (IGI = ∆I 0-60 /∆G 0-60 ); 2) the ratio of the IGI to the 149 HOMA-IR, which gives an adjusted measure of β-cell function that accounts for variations in 150 insulin sensitivity; 3) the ratio of the insulin to glucose areas under the curve 151 (AUC INS /AUC GLU ), which significantly correlates with glucose sensitivity and early-phase 152 insulin secretion, calculated by using the trapezoidal method from 0 to 120 min; and 4) the 153 total disposition index from 0 to 120 min (DI 120 ) by using the product of AUC INS /AUC GLU 154 with the Matsuda insulin sensitivity index, 16 which incorporates both the hepatic and muscle 155 components of insulin resistance and correlates well with the euglycemic insulin clamp. 
Statistical analyses 164
The summary data (the fasting and postprandial response) were analyzed by using one-factor 165 repeated-measures ANOVA. The incremental AUC (iAUC) was calculated by the trapezoidal 166 rule. The postprandial time courses after the test meals were analyzed by using 2-factor 167 repeated-measures ANOVA, and Bonferroni correction was applied for the post hoc detection 168 of significant pairwise differences. When indicated, hypothesis testing for differences 169 between groups was performed by the one-sample t test for independent samples. The data 170 were analyzed by using STATVIEW for WINDOWS (SAS Institute, Cary, NC). P < 0.05 was 171 considered significant. 172 These data indicated that all of the participants had similar basal β-cell function and insulin 182 sensitivity prior to the ingestion of the high-fat meals and the pharmacological dose of 183 immediate-release niacin. with SFAs, +474% with MUFAs, and +493% with MUFAs+omega-3 LCPUFAs vs. no fat, 212 100%) ( Table S2 in the Supporting Information). These effects of fat-enriched meals on 213 insulin were close to those observed on C-peptide, with a marked increase (P < 0.05) to a 214 peak at 60 min (2608 ± 229 pmol/l with SFAs, 2219 ± 120 pmol/l with MUFAs, and 2235 ± 215 AUC INS /AUC GLU (0-120 min), and DI 120 (0-120 min) were higher (P < 0.05) after the high-fat 224 meals than after the meal containing no fat plus niacin, and these estimates were higher (P < 225 0.05) after the SFA meal when compared to the MUFA and MUFA+omega-3 LCPUFA meals 226 (Table 2 ). In addition, estimates of postprandial insulin sensitivity, including IS 0-∞ (0-480 227 min) and the postprandial Belfiore indices for glycemia and blood FFAs (0-480 min), were 228 lower (P < 0.05) after the high-fat meals than after the meal containing no fat plus niacin. 229
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SUPPORTING INFORMATION
• Fatty acid composition of dietary fats.
• Fasting values on triglycerides, free fatty acids, glucose, insulin, and C-peptide.
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